公开(公告)号：US20200216564A1

公开(公告)日：2020-07-09

申请号：US16688374

申请日：2019-11-19

Applicant: aTyr Pharma, Inc. ,  Pangu BioPharma Limited

Inventor： Jie ZHOU ,  Ching-Fun LAU ,  Zhiwen XU ,  Wing-Sze LO ,  Kristi Helen PIEHL ,  Leslie Ann GREENE

IPC: C07K16/40 ,  C12Q1/6886 ,  G01N33/573 ,  C12N9/00 ,  C12N15/113 ,  C12Q1/6876

Abstract: Isolated histidyl-tRNA synthetase splice variant polynucleotides and polypeptides having non-canonical biological activities are provided, as well as compositions and methods related thereto.

公开(公告)号：US20220098327A1

公开(公告)日：2022-03-31

申请号：US17355587

申请日：2021-06-23

Applicant: aTyr Pharma, Inc. ,  Pangu BioPharma Limited

Inventor： Jie ZHOU ,  Ching-Fun LAU ,  Zhiwen XU ,  Wing-Sze LO ,  Kristi Helen PIEHL ,  Leslie Ann GREENE

IPC: C07K16/40 ,  C12Q1/6886 ,  G01N33/573 ,  C12N9/00 ,  C12N15/113 ,  C12Q1/6876

Abstract: Isolated histidyl-tRNA synthetase splice variant polynucleotides and polypeptides having non-canonical biological activities are provided, as well as compositions and methods related thereto.

公开(公告)号：US20200231704A1

公开(公告)日：2020-07-23

申请号：US16842195

申请日：2020-04-07

Applicant: aTyr Pharma, Inc. ,  Pangu BioPharma Limited

Inventor： Jie ZHOU ,  Ching-Fun LAU ,  Zhiwen XU ,  Wing-Sze LO ,  Kristi Helen PIEHL ,  Leslie Ann GREENE

IPC: C07K16/40 ,  C12Q1/6876 ,  C12N15/113 ,  C12Q1/6886 ,  C12N9/00 ,  G01N33/573

Abstract: Isolated histidyl-tRNA synthetase splice variant polynucleotides and polypeptides having non-canonical biological activities are provided, as well as compositions and methods related thereto.

公开(公告)号：US20240092917A1

公开(公告)日：2024-03-21

申请号：US18477113

申请日：2023-09-28

Applicant: aTyr Pharma, Inc.

Inventor： Luke BURMAN ,  Yeeting CHONG ,  Leslie Ann GREENE ,  David KING ,  Zhiwen XU ,  Ryan Andrew ADAMS

IPC: C07K16/28 ,  A61K39/395 ,  A61P35/00 ,  A61P35/04

CPC classification number: C07K16/2863 ,  A61K39/3955 ,  A61P35/00 ,  A61P35/04 ,  A61K2039/505

Abstract: Provided are affinity matured and humanized antibodies and antigen-binding fragments thereof that specifically bind to human neuropilin-2 (NRP2) polypeptides, including those that modulate binding interactions between human NRP2 and at least one NRP2 ligand, and which thereby modulate subsequent NRP2-mediated downstream signaling events, including related therapeutic compositions and methods for modulating NRP2 activity and treating diseases such as NRP2-associated diseases.

公开(公告)号：US20230312730A1

公开(公告)日：2023-10-05

申请号：US18048345

申请日：2022-10-20

Applicant: aTyr Pharma, Inc.

Inventor： Luke G. BURMAN ,  Yee Ting (Esther) CHONG ,  Yanyan GENG ,  Leslie Nangle GREENE ,  Kristina HAMEL ,  David KING ,  Ann MENEFEE ,  Kaitlyn RAUCH ,  Zhiwen XU ,  Liting ZHAI

IPC: C07K16/28 ,  A61K45/06 ,  A61K39/395 ,  G01N33/68

CPC classification number: C07K16/2863 ,  A61K39/3955 ,  A61K45/06 ,  G01N33/6854 ,  C07K2317/33 ,  C07K2317/34 ,  C07K2317/52 ,  C07K2317/55 ,  C07K2317/565 ,  C07K2317/71 ,  C07K2317/72 ,  C07K2317/76 ,  C07K2317/92

Abstract: Provided are antibodies and antigen-binding fragments thereof that specifically bind to human neuropilin-2 (NRP2) polypeptides, including those that modulate binding interactions between human NRP2 and at least one NRP2 ligand, for example, human histidyl-tRNA synthetase (HRS), and which thereby modulate subsequent NRP2-mediated downstream signaling events, including related therapeutic compositions and methods for modulating NRP2 activity and treating diseases such as NRP2-associated diseases.

公开(公告)号：US20210163606A1

公开(公告)日：2021-06-03

申请号：US17062100

申请日：2020-10-02

Applicant: aTyr Pharma, Inc.

Inventor： Luke BURMAN ,  Yeeting CHONG ,  Leslie Ann GREENE ,  David KING ,  Zhiwen XU ,  Ryan Andrew ADAMS

IPC: C07K16/28 ,  A61K33/243 ,  A61K39/395 ,  A61P35/00 ,  A61P35/04 ,  A61K31/513

Abstract: Provided are affinity matured and humanized antibodies and antigen-binding fragments thereof that specifically bind to human neuropilin-2 (NRP2) polypeptides, including those that modulate binding interactions between human NRP2 and at least one NRP2 ligand, and which thereby modulate subsequent NRP2-mediated downstream signaling events, including related therapeutic compositions and methods for modulating NRP2 activity and treating diseases such as NRP2-associated diseases.

公开(公告)号：US20190309076A1

公开(公告)日：2019-10-10

申请号：US16376979

申请日：2019-04-05

Applicant: aTyr Pharma Inc.

Inventor： Luke BURMAN ,  Yee Ting (Esther) CHONG ,  Yanyan GENG ,  Leslie Nangle GREENE ,  Kristina HAMEL ,  David KING ,  Ann MENEFEE ,  Kaitlyn RAUCH ,  Zhiwen XU ,  Liting ZHAI

IPC: C07K16/28 ,  A61K45/06 ,  A61K39/395 ,  G01N33/68

Abstract: Provided are antibodies and antigen-binding fragments thereof that specifically bind to human neuropilin-2 (NRP2) polypeptides, including those that modulate binding interactions between human NRP2 and at least one NRP2 ligand, for example, human histidyl-tRNA synthetase (HRS), and which thereby modulate subsequent NRP2-mediated downstream signaling events, including related therapeutic compositions and methods for modulating NRP2 activity and treating diseases such as NRP2-associated diseases